146 related articles for article (PubMed ID: 1752784)
21. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
22. Changes of circulating immune complexes in the serum and CSF of patients with multiple sclerosis.
Cojocaru M; Cojocaru MI; Steriu O; Băldescu R
Rom J Intern Med; 1992; 30(1):51-6. PubMed ID: 1496259
[TBL] [Abstract][Full Text] [Related]
23. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
24. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
[TBL] [Abstract][Full Text] [Related]
27. IgA immune complexes in patients with dermatitis herpetiformis occur in the absence of IgA rheumatoid factor.
Hall RP; Eyre RW
J Invest Dermatol; 1987 Jul; 89(1):27-31. PubMed ID: 3298445
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients.
Iaffaioli RV; Bianchin A; Ruggiero G; Pirozzi G; Ungaro A; Totaro G; Gallo C; De Placido S; Pagliarulo C; Bianco AR
Oncology; 1988; 45(5):337-43. PubMed ID: 3412739
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal follow-up circulating immune complexes of the serum in patients with breast cancer.
Nekulová M; Tomanová J; Lang BA
Neoplasma; 1982; 29(5):573-7. PubMed ID: 7177247
[TBL] [Abstract][Full Text] [Related]
30. Infectious immune complexes in HIV-1-infected patients.
Fiscus SA; Folds JD; van der Horst CM
Viral Immunol; 1993; 6(2):135-41. PubMed ID: 8216713
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
32. Clinical importance of circulating immune complexes in human acute lymphoblastic leukemia.
Croce MV; Fejes M; Riera N; Minoldo DA; Segal-Eiras A
Cancer Immunol Immunother; 1985; 20(1):91-5. PubMed ID: 3877563
[TBL] [Abstract][Full Text] [Related]
33. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY; Ton TC
Cancer Invest; 1991; 9(2):137-43. PubMed ID: 1713804
[TBL] [Abstract][Full Text] [Related]
34. Hydatid disease: analysis of parasite antigens in circulating immune complexes and in preformed hydatid antigen-antibody complexes.
D'Amelio R; De Rosa F; Pontesilli O; Dayal R; Brighouse G; Teggi A; Barnet M; Lambert PH
Med Microbiol Immunol; 1989; 178(3):177-86. PubMed ID: 2664438
[TBL] [Abstract][Full Text] [Related]
35. Serial circulating immune complex values and development of metastatic disease in breast cancer and malignant melanoma patients.
Ronai Z; Shaham J; Stein J; Sulitzeanu D
Cancer Immunol Immunother; 1986; 22(1):72-5. PubMed ID: 3518930
[TBL] [Abstract][Full Text] [Related]
36. [Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases].
Kovcin V; Juranić Z; Babović N; Tomasević Z
Srp Arh Celok Lek; 1997; 125(5-6):154-6. PubMed ID: 9265236
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of circulating immune complexes in patients with breast cancer.
Bukh A; Aguado MT; Krarup N; Poulsen HS; Nordentoft AM; Møller NP
Int J Cancer; 1988 Mar; 41(3):364-70. PubMed ID: 3257943
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of circulating immune complexes in cutaneous diseases associated with immune disorders.
Fernández Bussy R; Crisci CD; Fiorenza G; Bertoya N
Allergol Immunopathol (Madr); 1990; 18(1):47-52. PubMed ID: 2143349
[TBL] [Abstract][Full Text] [Related]
39. Circulating immune complexes in malignant melanoma: serial studies in 130 patients.
Bharwani N; Campbell L; Ashley P; Queen WD; Phillips TM; Jerry LM
Oncology; 1986; 43(3):143-8. PubMed ID: 3703459
[TBL] [Abstract][Full Text] [Related]
40. Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features.
Mozzana R; Baldini L; Neri A; Cortelezzi A; Radaelli F; Colajori E; Polli EE
Boll Ist Sieroter Milan; 1982; 61(4):324-9. PubMed ID: 6927220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
